Biothera Acquires MUC1 Anti-Cancer Monoclonal Antibody From Antisoma PLC
Published: Mar 10, 2011
EAGAN, Minn.--(BUSINESS WIRE)--Biothera announced today that it has acquired the anti-cancer monoclonal antibody AS1402 from Antisoma for undisclosed terms.